ArticleMedicine2016

Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study.

Ming-Che Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.